CBD for Cannabis Cessation: Mechanisms, Vaping, and Regulatory Framework

In a journey aimed at reducing or stopping the consumption of narcotic cannabis, cannabidiol (CBD) is generating legitimate interest as a support for well-being. Recreational cannabis with a high tetrahydrocannabinol (THC) content causes physical and psychological dependence, often accompanied by sleep, mood, and memory disorders. Given the tightening of European regulations on hemp-based food products, it is appropriate to approach withdrawal by combining scientific data on CBD with legal methods of consumption.

1. THC and CBD: Two Cannabinoids with Distinct Properties

To understand the action of cannabidiol in a withdrawal journey, it is important to distinguish between the components of the hemp plant:

• Tetrahydrocannabinol (THC): This is the psychoactive substance classified as a narcotic. THC binds directly to brain receptors, alters perceptions, and induces habituation.
• Cannabidiol (CBD): Non-psychotropic and devoid of narcotic effects, CBD does not cause intoxication or dependence. To better understand its biological interaction, you can discover how the endocannabinoid system works.

2. CBD's Action on the Endocannabinoid System and Withdrawal

When THC intake is interrupted, the body goes through an adjustment period marked by stress, irritability, or insomnia. CBD offers valuable support:

• Preservation of anandamide: THC disrupts the synthesis of anandamide, a neurotransmitter essential for mood regulation. CBD slows down the breakdown of anandamide, promoting nervous balance without altering alertness.
• Scientific research results: A study published in the journal Addictive Behaviors shows that CBD use helps regular consumers reduce their THC intake while mitigating withdrawal symptoms.
• Managing behavioral habits: Stopping joints often involves both THC dependence and tobacco addiction. Using non-combustible inhalation methods allows one to break away from toxic combustion.

3. Novel Food Regulatory Framework and Authorized Forms

The General Directorate for Food (DGAL) strictly applies the European Novel Food regulation (EU 2015/2283). In the absence of EFSA authorization, CBD products intended for ingestion (food oils, gummies, capsules, herbal teas) cannot be marketed as food.

In this specified legal context, withdrawal support relies on non-ingestible forms that are strictly compliant (< 0.3% THC):

• Vaporization of organic flowers and resins: Using a botanical vaporizer allows you to inhale cannabinoids without combustion or tobacco, thus preserving the respiratory tract. In this regard, you can discover our organic CBD flowers or explore our French CBD resins.
• CBD e-liquids: Reserved for vaping, they provide rapid assimilation to calm the need for the ritual without combustion.

To ensure an optimal experience free of unwanted chemical compounds, always be sure to avoid synthetic molecules and understand how the entourage effect works. You can also consult our dossier on Medical Cannabis in France: Experimentation, ANSM, and Status.

Reminder: CBD is not a medicine and cannot replace medical treatment for addiction. Support from a healthcare professional or an addiction specialist remains the recommended approach.

SOURCES: https://www.emcdda.europa.eu/publications/drug-profiles/cannabis_fr | https://www.canada.ca/fr/sante-canada/services/drogues-medicaments/cannabis/effets-sante/dependence.html | National Library of Medicine | Le Petit Livre du CBD, Pr. Nicolas Autier